Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 1/20 | 1.00 |
| ▸ | PRKCA | P17252 | 4/20 | 0.84 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.84 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.84 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.84 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.77 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.77 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.77 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.75 |
| ▸ | MAPT | P10636 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tripalmitin SCHEMBL3239772 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| Tripalmitin SCHEMBL2017107 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL896399 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL24334742 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL24333834 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL24333843 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL23612380 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL24334040 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL22973398 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL9717938 | 1.00 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11899027-B2 | Diagnostic methods based on lipid profiles | RUBIO METABOLOMICS, S.L.U. (ES) | 2024-02-13 | — | — | US | claimed |
| US-20220308075-A1 | LIPID PROFILING METHODS FOR PREDICTING POSITIVE PREGNANCY OUTCOME | HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. (IL) | 2022-09-29 | — | — | US | claimed |
| CN-114544924-A | Application of glyceride in disease prediction | 中国科学院上海营养与健康研究所 | 2022-05-27 | — | — | CN | claimed |
| US-20200155575-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2020-05-21 | — | — | US | claimed |
| US-20190269700-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2019-09-05 | — | — | US | claimed |
| US-20180078568-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2018-03-22 | — | — | US | claimed |
| US-20160184324-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-06-30 | — | — | US | claimed |
| US-20260000768-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | BEIJING BAISHIHEKANG PHARMACEUTICAL TECH BSJPHARMA CO LTD (CN) | 2026-01-01 | — | — | US | disclosed |
| US-20250345290-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | BEIJING BAISHIHEKANG PHARMACEUTICAL TECH BSJPHARMA CO LTD (CN) | 2025-11-13 | — | — | US | disclosed |
| US-20250264481-A1 | METHODS FOR PREDICTION AND EARLY DETECTION OF DIABETES | Baker Heart and Diabetes Institute (AU) | 2025-08-21 | — | — | US | disclosed |
| US-12313634-B2 | Methods for prediction and early detection of diabetes | ZORA BIOSCIENCES OY (FI) | 2025-05-27 | — | — | US | disclosed |
| US-20250166821-A1 | METHODS FOR PREDICTION OF TREATMENT RESPONSE IN NON-ALCOHOLIC FATTY LIVER DISEASE | SAGIMET BIOSCIENCES INC. | 2025-05-22 | — | — | US | disclosed |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | INSTITUTE OF BASIC MEDICAL SCIENCES (CN) | 2025-04-22 | — | — | US | disclosed |
| US-20160193225-A1 | (17-ß)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-07-07 | — | — | US | disclosed |
| US-20160184324-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-06-30 | — | — | US | disclosed |
| WO-2016033611-A1 | (17-β)-3-OXOANDROST-4-EN-17-YL UNDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| WO-2016033536-A1 | PHARMACEUTICAL COMPOSITION AND METHODS | LIPOCINE INC. (US) | 2016-03-03 | — | — | WO | disclosed |
| US-5690985-A | SELECTING A BLEND OF SPREAD FATS, ADDING A 2-ELAIDOYLTRIACYLGLYCEROL AND FORMING AN EDIBLE EMULSION | VAN DEN BERGH FOODS CO., DIVISION OF CONOPCO, INC. (US) | 1997-11-25 | — | — | US | disclosed |
| EP-0498487-B1 | Improvements in edible fats | UNILEVER NV (NL) | 1995-04-26 | — | — | EP | disclosed |
| EP-0498487-A1 | Improvements in edible fats | UNILEVER N.V. (NL) | 1992-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260000768-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS | FABP2, NSUN2, TRDMT1 | ALDH1A1 3856/4885LMNA 118/4885PRKCA 1593/4885 |
| US-20250345290-A1 | APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF | TRDMT1, HNRNPAB, HNRNPA1 | ALDH1A1 4559/4885LMNA 309/4885PRKCA 2378/4885 |
| US-12280114-B2 | Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products | CHMP4B, FIP1L1, LIPC | ALDH1A1 3396/4885LMNA 315/4885PRKCA 55/4885 |
| US-20250166821-A1 | METHODS FOR PREDICTION OF TREATMENT RESPONSE IN NON-ALCOHOLIC FATTY LIVER DISEASE | ACACB, ACACA, ACLY | ALDH1A1 554/4885LMNA 3283/4885PRKCA 1036/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.